Unsupervised clustering identified five tumor subsets: a group of tumors displayed stemness-like signatures, associated with PTEN and p53 inactivation and had a very survival outcome; a second group is characterized by TMPRSS2-ERG fusion and is associated with intermediate survival outcome; three other groups were associated with benign outcome [344]. The gene discussed is TP53; the disease is neoplasm.